PuSH - Publikationsserver des Helmholtz Zentrums München

22 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Balluff, B.* et al.: Integrative clustering in mass spectrometry imaging for enhanced patient stratification. Proteomics Clin. Appl. 13:e1800137 (2019)
2.
Huber, K. et al.: Multimodal analysis of formalin-fixed and paraffin-embedded tissue by MALDI imaging and fluorescence in situ hybridization for combined genetic and metabolic analysis. Lab. Invest., accepted (2019)
3.
Aichler, M. et al.: Molecular similarities and differences from human pulmonary fibrosis and corresponding mouse model: MALDI imaging mass spectrometry in comparative medicine. Lab. Invest. 98, 141-149 (2018)
4.
Buck, A. et al.: Round robin study of formalin-fixed paraffin-embedded tissues in mass spectrometry imaging. Anal. Bioanal. Chem. 410, 5969–5980 (2018)
5.
Suwandhi, L. et al.: Chronic d-serine supplementation impairs insulin secretion. Mol. Metab., accepted (2018)
6.
Zoni, E.* et al.: Metabolic signature in lethal vs. nonlethal prostate cancer. Cancer Res. 78, 61-62 (2018)
7.
Aichler, M. et al.: N-acyl taurines and acylcarnitines cause an imbalance in insulin synthesis and secretion provoking β cell dysfunction in type 2 diabetes. Cell Metab. 25, 1334-1347.e4 (2017)
8.
Buck, A. ; Aichler, M. ; Huber, K. & Walch, A.K.: In situ metabolomics in cancer by mass spectrometry imaging. Adv. Cancer Res. 134, 117-132 (2017)
9.
Düwel, S.* et al.: Imaging of pH in vivo using hyperpolarized 13C-labelled zymonic acid. Nat. Commun. 8:15126 (2017)
10.
Fichter, C.D.* et al.: A new model system identifies EGFR/HER2 and HER2/HER3 heterodimers as potent inducers of oesophageal epithelial cell invasion. J. Pathol. 243, 481-495 (2017)
11.
Kunzke, T. et al.: Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome. Oncotarget 8, 68012-68025 (2017)
12.
Urban, C. et al.: PAXgene fixation enables comprehensive metabolomic and proteomic analyses of tissue specimens by MALDI MSI. Biochim. Biophys. Acta 1862, 51-60 (2017)
13.
Buck, A. et al.: How suitable is MALDI-TOF for metabolite imaging from clinical formalin-fixed and paraffin-embedded tissue samples in comparison to MALDI-FT-ICR mass spectrometry? Anal. Chem. 88, 5281-5289 (2016)
14.
Lahiri, S.* ; Sun, N. ; Buck, A. ; Imhof, A.* & Walch, A.K.: MALDI imaging mass spectrometry as a novel tool for detecting histone modifications in clinical tissue samples. Expert Rev. Proteomics 13, 275-284 (2016)
15.
Ly, A. et al.: High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue. Nat. Protoc. 11, 1428-1443 (2016)
16.
Buck, A. et al.: Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSI. Anal. Bioanal. Chem. 407, 2107-2116 (2015)
17.
Buck, A. et al.: High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed paraffin-embedded clinical tissue samples. J. Pathol. 237, 123–132 (2015)
18.
Buck, A. & Walch, A.K.: In situ drug and metabolite analyzes in biological and clinical research by MALDI MS imaging. Bioanalysis 6, 1241-1253 (2014)
19.
Huber, K. et al.: A rapid ex vivo tissue model for optimising drug detection and ionisation in MALDI imaging studies. Histochem. Cell Biol. 142, 361-371 (2014)
20.
Li, Z.* et al.: FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy. Cancer Res. 72, 5014-5024 (2012)